Position in ABCL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$473,628
+$418,137 QoQ
Shares Held
60,335
+279.5% QoQ
Ownership
0.020%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#63
of 150 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABCL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WELLS FARGO & COMPANY/MN holds $1,567,775,044 across 417 Biotechnology names. ABCL ranks #189 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
749,528 | $372,313,040 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
1,390,428 | $108,828,797 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
310,047 | $93,333,446 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
140,802 | $87,795,677 | |
| 5 | EXEL |
Exelixis, Inc.
|
717,840 | $39,057,673 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
178,780 | $33,481,916 | |
| 7 | ARGX |
Argenx SE
|
34,453 | $31,964,458 | |
| 8 | INCY |
Incyte Corp
|
255,064 | $28,914,053 |
All Filings in ABCL
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $473,628 | 60,335 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $55,491 | 15,900 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $50,958 | 14,900 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $65,390 | 13,000 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $40,474 | 11,800 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $29,279 | 13,130 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $38,470 | 13,130 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $33,488 | 12,880 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $46,412 | 15,680 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $127,364 | 28,116 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $173,103 | 30,316 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $169,468 | 36,841 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $723,389 | 111,980 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $1,079,244 | 143,136 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $854,262 | 84,330 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $760,431 | 76,889 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $778,418 | 73,091 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $614,747 | 63,051 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,318,216 | 92,183 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $2,933,675 | 146,391 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,115,884 | 50,722 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $2,569,821 | 75,672 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $8,048 | 200 | Shares | Defined | 2021-02-09 | |
| No filing history on record for this holder in this stock. | ||||||